LARGE-SCALE USE OF SABIN TYPE-2 ATTENUATED POLIOVIRUS VACCINE IN SINGAPORE DURING A TYPE-1 POLIOMYELITIS EPIDEMIC

被引:53
作者
HALE, JH
DORAISINGHAM, M
KANAGARATNAM, K
LEONG, KW
MONTEIRO, ES
机构
关键词
D O I
10.1136/bmj.1.5137.1541
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1541 / 1549
页数:9
相关论文
共 14 条
[1]   A SMALL-SCALE TRIAL OF TYPE-III ATTENUATED LIVING POLIOVIRUS VACCINE [J].
CLARKE, SKR ;
GOFFE, AP ;
STUARTHARRIS, CH ;
HERZOG, EG .
BRITISH MEDICAL JOURNAL, 1958, 2 (NOV15) :1188-1193
[2]  
DICK GWA, 1957, BRIT MED J, V1, P70
[3]  
DICK GWA, 1957, BRIT MED J, V1, P65
[4]  
KOPROWSKI H, 1955, S Afr Med J, V29, P1134
[5]  
PAUL J R, 1958, Bull World Health Organ, V19, P747
[6]  
SABIN A, 1958, COMMUNICATION
[8]   PRESENT STATUS OF ATTENUATED LIVE-VIRUS POLIOMYELITIS VACCINE [J].
SABIN, AB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1956, 162 (18) :1589-1596
[9]   PROPERTIES AND BEHAVIOR OF ORALLY ADMINISTERED ATTENUATED POLIOVIRUS VACCINE [J].
SABIN, AB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1957, 164 (11) :1216-1223
[10]  
SABIN AB, 1957, NY ACAD SCI, V5, P113